Stoke Therapeutics Ownership & Insider Activity

Stoke Therapeutics (STOK) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.9% of shares outstanding. Institutional investors hold 53.6%. Over the past 90 days, insiders made 4 sales worth $658K.

Shares Outstanding

62.282M

Shares Float

59.878M

Insider Shares Owned

552.860K

Insider % Owned

0.9%

Institutional Shares Held

34.574M

Institutional % Held

53.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$658K total

Net Activity

Net Selling

Net Value (90d)

-$658K

Stoke Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	5.545K	$30.67	$170K
Aug 14, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL-OPTIONS	5.233K	$32.03	$153K
Aug 14, 2026	MD Edward Kaye	—	SELL-OPTIONS	13.683K	$32.03	$403K
Aug 14, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL-OPTIONS	3.139K	$32.03	$92K
Aug 3, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	7.176K	$29.04	$208K
Jul 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	7.228K	$32.66	$236K
Jun 16, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL	1.457K	$29.95	$44K
Jun 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	1.795K	$30.58	$55K
May 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	2.243K	$32.79	$74K
Apr 1, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	1.838K	$32.66	$60K
Mar 20, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL	9.293K	$33.69	$313K
Mar 17, 2026	Barry Ticho	CHIEF MEDICAL OFFICER	SELL	12.946K	$17.06	$454K
Mar 17, 2026	Thomas Leggett	CHIEF FINANCIAL OFFICER	SELL	4.578K	$32.14	$147K
Mar 17, 2026	Jason Hoitt	CHIEF PATIENT OFFICER	SELL	3.712K	$32.14	$119K
Mar 17, 2026	Jonathan Allan	GENERAL COUNSEL & CORP SEC	SELL	8.895K	$32.14	$286K
Mar 13, 2026	ARTHUR LEVIN	—	SELL	605.000	$36.80	$22K
Mar 10, 2026	ARTHUR TZIANABOS	INTERIM EXECUTIVE CHAIR	SELL	400.000	$24.17	$141K
Mar 10, 2026	Adrian Krainer	—	SELL	33.243K	$39.74	$1.3M